First Growth Capital’s Johnson & Johnson JNJ Stock Holding History

First Growth Capital’s Portfolio JNJ Stock Details JNJ Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$541K	Sell	2,131 -331	-13%	-$77.1K	0.41%	73
2026 Q1	$601K	Buy	2,462 +2	+0.1%	+$466	0.54%	49
2025 Q4	$593K	Buy	+2,460	New	+$486K	0.53%	48

Other funds holding JNJ

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

State Farm Mutual Automobile Insurance Bloomington, Illinois $146B AUM 55.73% 1-Year Est. Return

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

First Growth Capital's JNJ Position: Q2 2026 in Review

First Growth Capital reduced its Johnson & Johnson (JNJ) stake by 13% in Q2 2026, selling an estimated $77.1K and leaving 2,131 shares worth $541K. The position accounts for 0.41% of the portfolio, ranked #73.

First Growth Capital first reported a position in JNJ in Q4 2025 and has held it in 3 quarters since. The position peaked at $601K in Q1 2026. 4,677 funds tracked by Wall St. Rank hold JNJ as of Q2 2026.

First Growth Capital held 2,131 shares of Johnson & Johnson worth $541K as of Q2 2026.
First Growth Capital sold 331 Johnson & Johnson shares in Q2 2026, an estimated $77.1K.
Johnson & Johnson made up 0.41% of First Growth Capital's portfolio in Q2 2026, its #73 holding.
First Growth Capital first reported a position in Johnson & Johnson in Q4 2025 and has held it in 3 quarters since.
First Growth Capital's Johnson & Johnson position peaked at $601K in Q1 2026.
4,677 funds tracked by Wall St. Rank held Johnson & Johnson as of Q2 2026.

Based on First Growth Capital's 13F filing for Q2 2026, filed 16 Jul 2026.